STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Tibotec and Medivir (STO:MVIRB) scientists will jointly present the first preclinical data on TMC435350 at the 14th International Symposium on Hepatitis C Virus and Related Viruses in Glasgow, Scotland later this week.
